FDA will block its approval of a drug to treat the life-threatening condition cystic fibrosis, according to a regulatory filing that the agency has released to CricInfo.
The agency’s announcement came as the Federal Trade Commission is preparing to hold a hearing on a proposed rule on the use of blockchains to track drugs.
The rule is expected to be unveiled in late September.
Blockchain technology uses computers to record and verify transactions.
It’s a type of digital ledger that can store data on a wide variety of things, including health records, tax filings, financial transactions, and other financial transactions.
The FDA says the use will not harm patients or the public health system, and that the proposed rule will provide patients with more accurate information about drugs they’re taking.
It says it will also address privacy concerns about blockchain transactions.
The agency’s move comes after the Drug Enforcement Agency warned that blockchains may allow criminals to conduct money laundering and other criminal activities.
The DEA issued its warning in a recent report to Congress, saying blockchain technology could allow criminal groups to evade detection and capture billions of dollars in drug money.
“We believe that blockchain technology is a promising tool that can be leveraged to further improve the drug safety and efficacy of many pharmaceutical products, including many prescription drugs,” the agency wrote in its report.
“The DEA is committed to addressing the privacy concerns that arise when drugs are recorded and verified using blockchains.
DEA is also committed to promoting the use and adoption of blockchain technology in the drug industry.”
Blockchain and blockchain technologies have gained popularity in recent years, particularly as they help speed the completion of the blockchain technology process.
The blockchain is an open-source software platform that is run on computers, and its applications are open to the public.
The technology has been used to record the identities of drug users and drug manufacturers, including through a blockchain network called BlockApps.
The U.S. Federal Trade Administration also has a proposal to create an agency that would oversee the use, development, and sale of blockchain technologies.